⌘K

Login Start Free

Home/Filings/4/0001493152-22-032557

4//SEC Filing

Rachman Ilya M 4

Accession 0001493152-22-032557

CIK 0001873835other

View on SEC.gov Company Profile

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 5:33 PM ET

Size

7.4 KB

Accession

0001493152-22-032557

Insider Transaction Report

Form 4

Period: 2022-11-14

Immix Biopharma, Inc.IMMX

DirectorCEO and Chairman

Transactions

Purchase
Common Stock
2022-11-14$1.02/sh+4,050$4,127→ 906,550 total
Purchase
Common Stock
2022-11-14$0.95/sh+1,000$950→ 907,550 total
Purchase
Common Stock
2022-11-14$0.99/sh+150$149→ 907,700 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1

filerCIK 0001889334

Filing Metadata

Form type: 4
Filed: Nov 14, 7:00 PM ET
Accepted: Nov 15, 5:33 PM ET
Size: 7.4 KB

View on SEC.gov